- |||||||||| APN1125 / CoMentis, Alpharmagen
Enrollment closed, Trial primary completion date: Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects (clinicaltrials.gov) - Dec 25, 2015 P1, N=50, Active, not recruiting, Trial primary completion date: Jan 2016 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: May 2015 --> Jan 2016
|